GlobeNewswire by notified

UPDATE -- Quark Branches into New Era of Content Intelligence with Release of Quark Publishing Platform NextGen v3.0

Share

Self-service content automation platform streamlines enterprise content workflows with deeper analytics to measure content consumption patterns

In a release issued earlier today by Quark Software, the company is updating this release to include link for https://developer.quark.com

GRAND RAPIDS, Mich., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Quark Software, the global provider of content automation, intelligence and design software, today announced the newest release of Quark Publishing Platform (QPP) NextGen, its content automation platform designed to simplify the complexities associated with enterprise content lifecycle management from creation to consumption. QPP NextGen v3.0 takes self-service a giant step further with simplified role-based dashboards and now includes enhanced analytics capabilities to help enterprises accurately understand how published content is being consumed. Additional new features foster content team collaboration and productivity with the power to publish personalized, compliance-controlled content across any digital output fast.

“As global enterprises begin to understand the role content plays in supporting business growth, it brings to light the importance of modernizing content infrastructures and processes, and knowing how content is being consumed by their target audiences,” said Martin Owen, CEO at Quark. “Executing a successful content strategy is complex, and your content operations infrastructure is at the heart of this success. QPP NextGen has all the tools to automate each stage of the content lifecycle. For the first time, enterprises can move faster to market with compliance-controlled, omnichannel content with easy access to deep analytics to gain content consumption metrics and understand if their content really works for their business.”

According to a Forrester blog, The Quantum Physics of Future-Ready B2B Content, B2B organizations know that the digital experiences they deliver must be relevant and fueled with audience-centric content. However, fewer than 30% plan to focus on real-time, contextualized interaction capabilities in the next 12 months, although 74% recognize that buyers expect personalized interactions. Additionally, a recent IDC blog discusses the importance of organizations evaluating how they manage business content operations and the value of what they call a Unified Content Model brings to supporting their digital first business.

Quark has been in the content technology business for over 40 years and knows that content delivered must be personalized and reach the right audience at the right time and via the right device for optimal consumption. Quark understands that many organizations don’t know if their content is achieving the desired results and cannot measure true content ROI.

QPP NextGen addresses these complexities with automation capabilities to support multiple use cases with the power to manage large, complex documents at scale. Enterprises can create, manage and store structured, reusable content components with auto-generated XML metadata tags from Microsoft Word, collaborate across roles and departments to streamline reviews/approvals and eliminate duplicate efforts, and publish compliance-controlled content in multiple formats from a single source-of-truth CCMS with 100% accuracy.

New features and benefits available in the newest release of QPP NextGen include:

  • Granular Section-Level Analytics & Visual Intelligence– In addition to seeing content consumption patterns of an overall asset, organizations can understand how many individual components and sections of an asset are being consumed the most, with visibility into consumption analytics for each one. This helps organizations make smarter content creation and delivery decisions, and better understand when to reuse, repurpose or retire content. Newly available visual reports help content creators understand content success, trends and engagement patterns through easy-to-understand visuals such as charts and graphs.
  • Enriched UI - Team Collaboration and Workflow Productivity Enhancements – A personalized, streamlined UI delivers a single pane of glass view to easily address any stage – or all stages - of the content lifecycle. Users receive alerts for priority content workflows that need fast attention.
  • Interoperability of Structured Authoring Tools – To support a global workforce, content teams can collaborate in real-time between low-code / no-code Microsoft Word and Web browser authoring tools to maximize workflow productivity.
  • Version Branching – Content creators can expand content reach by creating regionalized, personalized and localized versions of content by cloning and branching off new ‘child components’ that are linked to original content.
  • Self-Service Content Modeling – SMEs can make real-time changes to content models, XML schematic architecture and format styles to support emerging document types, including regulatory changes and layout adjustments.

Additional Resources:

About Quark Software, Inc.
Quark knows content. The company revolutionized desktop publishing and today provides content automation, intelligence and design software for end-to-end content lifecycle management. Customers worldwide rely on Quark to modernize their content ecosystems so they can automate omnichannel publishing of mission-critical documents, analyze production and engagement insights for the greatest return on their content investments, and create complex print and digital layouts. Quark is backed by Parallax Capital Partners and headquartered in Grand Rapids, Mich., with offices in the United Kingdom, Ireland and India. Quark. Brilliant content that works. For more information, visit www.quark.com or follow us on LinkedIn.

Media Contacts:
Lisa Williams
Corporate Communications, Quark
lwilliams@quark.com
339.788.0067


To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Inteleos to Host Roundtable on Advancing Maternal Health through Point-Of-Care-Ultrasound Certification6.5.2024 23:25:48 CEST | Press release

Global healthcare certification leader convenes experts to discuss ultrasound training and certification as key strategy to reduce maternal mortality ROCKVILLE, Md., May 06, 2024 (GLOBE NEWSWIRE) -- Inteleos, a non-profit global healthcare certification organization, will host a roundtable discussion titled "Advancing Maternal and Fetal Health through POCUS Training and Certification" on May 29 alongside a side event during the WHO World Health Assembly and the AI for Good Global Summit. The roundtable will explore the urgent need to expand point-of-care ultrasound (POCUS) training and certification for frontline maternal health clinicians as a crucial intervention for reducing preventable maternal deaths and achieving UN Sustainable Development Goals, and how to implement to scale. Despite the increased availability of affordable ultrasound technology, there remains a significant training gap that limits access to this diagnostic tool, especially in low-resource areas with high matern

ETC’s Commercial/Industrial Units Awarded Three Contracts Totaling $15.9 Million6.5.2024 22:15:00 CEST | Press release

SOUTHAMPTON, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Environmental Tectonics Corporation’s (OTC Pink: ETCC) (“ETC” or the “Company”) Sterilization Systems Group announced it has been awarded $13.9 million in contracts from two multi-national medical device manufacturers. The contracts include four, sixteen pallet ethylene oxide (“EO”) sterilization system chambers with related conveyer systems, and a large capacity vacuum drying chamber with preconditioning. “These contracts reflect ETC Sterilization Systems Group’s dedication to innovation in our mechanical designs, control systems and software expertise to meet the challenging requirements of this market,” states Eric Hunnicutt, ETC Director of EO Sterilizer Sales. ETC’s Sterilization Systems Group offers Steam and Ethylene Oxide (“EO”) Sterilizer Systems, Vacuum Dryers, Software Systems, and project management services to the Medical Device, Pharmaceutical, Biotechnology, and Life Science industries. ETC’s systems are specially design

Merus Announces U.S. FDA Acceptance and Priority Review of Biologics License Application for Zeno for the Treatment of NRG1+ NSCLC and PDAC6.5.2024 22:05:00 CEST | Press release

If approved, Zeno will be the first targeted therapy for NRG1+ cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review a Biologics License Application (BLA) for the bispecific antibody zenocutuzumab (Zeno) in patients with neuregulin 1 fusion (NRG1+) non-small cell lung (NSCLC) and NRG1+ pancreatic (PDAC) cancer. “FDA acceptance of our first BLA represents an important achievement for Merus and an important potential treatment opportunity for patients with NRG1+ cancer, a disease with poor prognosis and high unmet need,” said Dr. Andrew Joe, Chief Medical Officer at Merus. “Zenocutuzumab has the potential to be the first and only targeted therapy for patients with NRG1+ lung and

Nokia Corporation: Repurchase of own shares on 06.05.20246.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 06 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 06.05.2024 Espoo, Finland – On 06 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL385,6823.45CEUX--BATE--AQEU--TQEX--Total385,6823.45 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

Trading in Novo Nordisk shares by board members, executives and associated persons6.5.2024 21:02:16 CEST | Press release

Bagsværd, Denmark, 06 May 2024 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons. Please find below a statement of such trading in shares issued by Novo Nordisk. 1 Details of the person discharging managerial responsibilities/person closely associated a) Name of the Board member/Executive/Associated Person Novo Holdings A/S, associated to Kasim Kutay 2 Reason for the notification a) Position/status Member of the Board of Directors b) Initial notification/Amendment Initial notification 3 Details of the issuer a) Name Novo Nordisk A&S b) LEI 549300DAQ1CVT6CXN342

HiddenA line styled icon from Orion Icon Library.Eye